Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04252339 · ClinicalTrials.gov registry record · Phase 1
RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors
A Phase 1 study, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
NCT04252339 is a Phase 1 study that has completed, run by Hoffmann-La Roche. The registered enrollment target is 56 participants.
The verdict
NCT04252339, a Phase 1 study, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
Study Summary
This study is a multi-center, open-label, dose escalation and expansion study of RLY-1971 in subjects with advanced or metastatic solid tumors.
Interventions
- DRUG RLY-1971
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2020-02-04 |
| Est. Completion | 2022-11-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04252339
The ClinicalTrials.gov registry entry for NCT04252339 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RLY-1971 is the first listed.
NCT04252339 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04252339 about?
NCT04252339 is a clinical study titled "RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors". This study is a multi-center, open-label, dose escalation and expansion study of RLY-1971 in subjects with advanced or metastatic solid tumors.
What is the current status of trial NCT04252339?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2020-02-04. Estimated completion is 2022-11-22.
What interventions are being tested in trial NCT04252339?
The interventions under investigation include: RLY-1971 (DRUG).
Who is sponsoring clinical trial NCT04252339?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.